Sulfadiazine is an organic compound and a sulfonamide antibiotic. It is a synthetic antibacterial agent that belongs to the class of "sulfa drugs," which were among the first effective systemic antibacterial agents used in medicine. It is typically administered orally.
Mechanism of Action Sulfadiazine exerts its antibacterial effect by interfering with the synthesis of folic acid, an essential nutrient for bacterial growth and replication. It acts as a competitive inhibitor of dihydropteroate synthase, an enzyme involved in the conversion of para-aminobenzoic acid (PABA) to dihydrofolic acid. Since bacteria must synthesize their own folic acid, and mammalian cells obtain preformed folic acid from their diet, sulfadiazine selectively targets bacterial metabolism. This inhibition prevents the formation of purines, pyrimidines, and amino acids, ultimately leading to a bacteriostatic (growth-inhibiting) effect rather than a direct bactericidal (bacteria-killing) one.
Uses and Indications Sulfadiazine is used to treat a variety of bacterial and protozoal infections. Its most significant current use is in combination with pyrimethamine for the treatment of toxoplasmosis, particularly in immunocompromised individuals such as those with HIV/AIDS. Other indications include:
- Nocardiosis: A severe bacterial infection.
- Rheumatic Fever Prophylaxis: To prevent recurrent episodes of rheumatic fever in patients with a history of the condition.
- Chancroid, Trachoma, Lymphogranuloma Venereum: Certain sexually transmitted infections.
- Urinary Tract Infections (UTIs): Historically used, though less common now due to increased bacterial resistance and the availability of newer antibiotics.
Pharmacokinetics Sulfadiazine is well absorbed from the gastrointestinal tract following oral administration. It distributes widely into various body tissues and fluids, including the cerebrospinal fluid, which is important for its efficacy in treating central nervous system infections. It undergoes metabolism in the liver, primarily through acetylation, and both the unchanged drug and its metabolites are primarily excreted by the kidneys. Adequate hydration is crucial during treatment to prevent crystalluria.
Adverse Effects Common adverse effects of sulfadiazine include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. More serious side effects can include:
- Hypersensitivity Reactions: Ranging from skin rashes, itching, and fever to severe conditions like Stevens-Johnson syndrome or toxic epidermal necrolysis.
- Hematologic Abnormalities: Agranulocytosis, aplastic anemia, hemolytic anemia (especially in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency), and thrombocytopenia.
- Renal Complications: Crystalluria (formation of crystals in the urine), which can lead to kidney stone formation and renal dysfunction, especially with insufficient fluid intake.
- Hepatotoxicity: Liver enzyme elevations or more severe liver damage.
- Central Nervous System Effects: Headaches, dizziness, and peripheral neuropathy.
Contraindications and Precautions Sulfadiazine is contraindicated in individuals with a known hypersensitivity to sulfonamides. It should not be used in infants under two months of age due to the risk of kernicterus (bilirubin encephalopathy). It is also generally avoided in late pregnancy and in nursing mothers. Caution is advised in patients with severe renal or hepatic impairment, porphyria, or G6PD deficiency. Patients should be advised to maintain adequate fluid intake to prevent renal complications.
Drug Interactions Sulfadiazine can potentiate the effects of oral anticoagulants (e.g., warfarin), methotrexate, and sulfonylureas, necessitating careful monitoring and dose adjustments. It may also interact with phenytoin and other drugs.